BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

840 related articles for article (PubMed ID: 16555967)

  • 1. Animal carcinogenicity studies: implications for the REACH system.
    Knight A; Bailey J; Balcombe J
    Altern Lab Anim; 2006 Mar; 34 Suppl 1():139-47. PubMed ID: 16555967
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Are tumor incidence rates from chronic bioassays telling us what we need to know about carcinogens?
    Gaylor DW
    Regul Toxicol Pharmacol; 2005 Mar; 41(2):128-33. PubMed ID: 15698536
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Animal carcinogenicity studies: 1. Poor human predictivity.
    Knight A; Bailey J; Balcombe J
    Altern Lab Anim; 2006 Feb; 34(1):19-27. PubMed ID: 16522147
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epidemiological and experimental applications to occupational cancer prevention.
    Vainio H; Hemminki K
    J UOEH; 1989 Mar; 11 Suppl():323-45. PubMed ID: 2664947
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of reduced protocols for carcinogenicity testing of chemicals: report of a joint EPA/NIEHS workshop.
    Lai DY; Baetcke KP; Vu VT; Cotruvo JA; Eustis SL
    Regul Toxicol Pharmacol; 1994 Apr; 19(2):183-201. PubMed ID: 8041916
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Animal carcinogenicity studies: 2. Obstacles to extrapolation of data to humans.
    Knight A; Bailey J; Balcombe J
    Altern Lab Anim; 2006 Feb; 34(1):29-38. PubMed ID: 16522148
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of the ability of a battery of three in vitro genotoxicity tests to discriminate rodent carcinogens and non-carcinogens II. Further analysis of mammalian cell results, relative predictivity and tumour profiles.
    Kirkland D; Aardema M; Müller L; Makoto H
    Mutat Res; 2006 Sep; 608(1):29-42. PubMed ID: 16769241
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of the utility of the lifetime mouse bioassay in the identification of cancer hazards for humans.
    Osimitz TG; Droege W; Boobis AR; Lake BG
    Food Chem Toxicol; 2013 Oct; 60():550-62. PubMed ID: 23954551
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The transgenic mouse assay as an alternative test method for regulatory carcinogenicity studies--implications for REACH.
    Wells MY; Williams ES
    Regul Toxicol Pharmacol; 2009 Mar; 53(2):150-5. PubMed ID: 19126422
    [TBL] [Abstract][Full Text] [Related]  

  • 10. NTP toxicology and carcinogenesis studies of 3,3',4,4',5-pentachlorobiphenyl (PCB 126) (CAS No. 57465-28-8) in female Harlan Sprague-Dawley rats (Gavage Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 2006 Jan; (520):4-246. PubMed ID: 16628245
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of the carcinogenicity of 1,1-dichloroethylene (vinylidene chloride).
    Roberts SM; Jordan KE; Warren DA; Britt JK; James RC
    Regul Toxicol Pharmacol; 2002 Feb; 35(1):44-55. PubMed ID: 11846635
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of quantitative structure-activity relationship (QSAR) models to predict the carcinogenic potency of chemicals. II. Using oral slope factor as a measure of carcinogenic potency.
    Wang NC; Venkatapathy R; Bruce RM; Moudgal C
    Regul Toxicol Pharmacol; 2011 Mar; 59(2):215-26. PubMed ID: 20951756
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of mouse liver tumor data in risk assessments performed by the U.S. Environmental Protection Agency.
    Beal DD
    Prog Clin Biol Res; 1990; 331():5-18. PubMed ID: 2179964
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Carcinogenic chemical-response "fingerprint" for male F344 rats exposed to a series of 195 chemicals: implications for predicting carcinogens with transgenic models.
    Johnson FM
    Environ Mol Mutagen; 1999; 34(4):234-45. PubMed ID: 10618171
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Carcinogenicity categorization of chemicals-new aspects to be considered in a European perspective.
    Bolt HM; Foth H; Hengstler JG; Degen GH
    Toxicol Lett; 2004 Jun; 151(1):29-41. PubMed ID: 15177638
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Databases applicable to quantitative hazard/risk assessment--towards a predictive systems toxicology.
    Waters M; Jackson M
    Toxicol Appl Pharmacol; 2008 Nov; 233(1):34-44. PubMed ID: 18675838
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The weight of the evidence among group C carcinogens.
    Engler R; Rinde E; Frick C; Quest J
    Qual Assur; 1991 Oct; 1(1):51-69. PubMed ID: 1669970
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prediction of rodent carcinogenic potential of naturally occurring chemicals in the human diet using high-throughput QSAR predictive modeling.
    Valerio LG; Arvidson KB; Chanderbhan RF; Contrera JF
    Toxicol Appl Pharmacol; 2007 Jul; 222(1):1-16. PubMed ID: 17482223
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Safety and nutritional assessment of GM plants and derived food and feed: the role of animal feeding trials.
    EFSA GMO Panel Working Group on Animal Feeding Trials
    Food Chem Toxicol; 2008 Mar; 46 Suppl 1():S2-70. PubMed ID: 18328408
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alleged misconceptions' distort perceptions of environmental cancer risks.
    Tomatis L; Melnick RL; Haseman J; Barrett JC; Huff J
    FASEB J; 2001 Jan; 15(1):195-203. PubMed ID: 11149907
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 42.